Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.8200
+0.0950 (13.10%)
At close: Nov 4, 2025, 4:00 PM EST
0.6241
-0.1959 (-23.89%)
After-hours: Nov 4, 2025, 7:59 PM EST
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $29.31 million as of November 4, 2025. Its market cap has increased by 10.94% in one year.
Market Cap
29.31M
Enterprise Value
28.14M
1-Year Change
10.94%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $29.31M, a decrease of -89.95%. That is a compound annual growth rate of -20.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 25.91M | -19.77% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | 71.18M | 93.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |